Anagenics Ltd Market Cap ($4.18 Million)
Market Cap & Net Worth: Anagenics Ltd (AN1)
Anagenics Ltd market cap. Anagenics Ltd (AU:AN1) has a market capitalization of $4.18 Million (AU$5.91 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28841 globally and #1544 in its home market, demonstrating a 20.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anagenics Ltd's stock price AU$0.01 by its total outstanding shares 985450795 (985.45 Million). Also see Anagenics Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Anagenics Ltd Market Cap History (2015–2026)
Anagenics Ltd market cap history from 2015 to 2026. Data shows change from $308.61 Million to $4.18 Million (-33.58% CAGR). Check Anagenics Ltd (AN1) share price today for real-time trading data and today's change.
Anagenics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anagenics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Anagenics Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.81x
Anagenics Ltd's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.56x
Anagenics Ltd's market cap is 13.56 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $327.86 Million | $4.50 Million | -$4.47 Million | 72.92x | N/A |
| 2018 | $180.03 Million | $5.65 Million | -$3.73 Million | 31.88x | N/A |
| 2019 | $141.41 Million | $7.30 Million | -$5.91 Million | 19.37x | N/A |
| 2020 | $70.70 Million | $7.38 Million | -$4.91 Million | 9.58x | N/A |
| 2021 | $41.42 Million | $5.82 Million | -$3.39 Million | 7.12x | N/A |
| 2022 | $17.29 Million | $6.95 Million | -$3.65 Million | 2.49x | N/A |
| 2023 | $13.25 Million | $9.11 Million | -$2.67 Million | 1.45x | N/A |
| 2024 | $5.58 Million | $10.80 Million | -$7.49 Million | 0.52x | N/A |
| 2025 | $3.49 Million | $4.75 Million | -$1.24 Million | 0.73x | N/A |
| 2026 | $4.18 Million | $5.16 Million | $308.47K | 0.81x | 13.56x |
Competitor Companies of AN1 by Market Capitalization
Companies near Anagenics Ltd in the global market cap rankings as of November 8, 2026. Also see AN1 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Anagenics Ltd by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #38 globally with a market cap of $373.42 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #97 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #98 globally with a market cap of $204.16 Billion USD ( €174.63 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #196 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #38 | Procter & Gamble Company | NYSE:PG | $373.42 Billion | $165.40 |
| #97 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #98 | LOréal S.A. | PA:OR | $204.16 Billion | €449.80 |
| #196 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Market Capitalization of Anagenics Ltd (2015–2026)
Market capitalization of Anagenics Ltd from 2015 to today. Between 2015 and today, Anagenics Ltd's market cap moved from $308.61 Million to $ 4.18 Million, with a yearly change of -33.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$4.18 Million | +20.00% |
| 2025 | AU$3.49 Million | -37.50% |
| 2024 | AU$5.58 Million | -57.89% |
| 2023 | AU$13.25 Million | -23.39% |
| 2022 | AU$17.29 Million | -58.25% |
| 2021 | AU$41.42 Million | -41.42% |
| 2020 | AU$70.70 Million | -50.00% |
| 2019 | AU$141.41 Million | -21.46% |
| 2018 | AU$180.03 Million | -45.09% |
| 2017 | AU$327.86 Million | -1.94% |
| 2016 | AU$334.34 Million | +8.34% |
| 2015 | AU$308.61 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Anagenics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.18 Million USD |
| MoneyControl | $4.18 Million USD |
| MarketWatch | $4.18 Million USD |
| marketcap.company | $4.18 Million USD |
| Reuters | $4.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anagenics Ltd
Anagenics Limited engages in the health, wellness, and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the P… Read more